The future of the development of medicines in idiopathic pulmonary fibrosis

Por Fregonese, Laura, Eichler, Irmgard
Publicado no BMC Med (2015)

The K(+) Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis Patients

Por Roth, Eva K., Hirtz, Stephanie, Duerr, Julia, Wenning, Daniel, Eichler, Irmgard, Seydewitz, Hans H., Amaral, Margarida D., Mall, Marcus A.
Publicado em 2011

Minimal acute rejection in pediatric lung transplantation does it matter?

Por Benden, Christian, Faro, Albert, Worley, Sarah, Arrigain, Susana, Aurora, Paul, Ballmann, Manfred, Boyer, Debra, Conrad, Carol, Eichler, Irmgard, Elidemir, Okan, Goldfarb, Samuel, Mallory, George B, Mogayzel, Peter J, Parakininkas, Daiva, Solomon, Melinda, Visner, Gary, Sweet, Stuart C, Danziger-Isakov, Lara A
Publicado em 2010

Meeting Report: Harmonization of RSV therapeutics – from design to performance

Por Nair, Harish, Ramilo, Octavio, Eichler, Irmgard, Pelfrene, Eric, Mejias, Asuncion, Polack, Fernando P, Pouwels, Koen B., Langley, Joanne M., Nunes, Marta, van der Maas, Nicoline, Kragten–Tabatabaie, Leyla, Baraldi, Eugenio, Heikkinen, Terho, Fauroux, Brigitte, Sharland, Mike, Park, Cyrus, Manzoni, Paolo, Papadopoulos, Nikolaos G., Martinón–Torres, Federico, Stein, Renato, Bont, Louis
Publicado no J Glob Health (2016)